- Conditions: Acute Schizophrenia; Schizoaffective Disorder
Interventions: Drug: RP5063; Drug: placebo; Drug: RP5063; Drug: RP5063; Drug: aripiprazole
Sponsors: Reviva Pharmaceuticals; Reviva Pharmaceuticals
Recruiting - verified December 2011 - Condition: Bipolar I Disorder
Intervention: Drug: Lithium/Matching Placebo and an SGA (Second Generation Antipsychotic)
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; National Institutes of Health (NIH)
Recruiting - verified December 2011 - Condition: Schizophrenia
Intervention: Drug: Aripiprazole (Abilify®) IM Depot Injection
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified November 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Augmenting: Antidepressant + Aripiprazole; Drug: Augmenting: Antidepressant + Bupropion-SR; Drug: Switching: Bupropion-SR
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Condition: Tourette's Disorder
Intervention: Drug: aripiprazole
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified January 2012 - Condition: Tourette's Disorder
Intervention: Drug: aripiprazole
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified January 2012 - Condition: Tourette's Disorder
Intervention: Drug: aripiprazole
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified April 2012 - Condition: Schizophrenia
Interventions: Drug: LY2140023; Drug: Aripiprazole
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified March 2012 - Condition: Alcohol Dependence
Interventions: Drug: Aripiprazole; Drug: Placebo
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified April 2012 - Condition: Autistic Disorder
Interventions: Drug: Aripiprazole; Drug: Placebo
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified February 2012 - Condition: Autistic Disorder
Interventions: Drug: Aripiprazole; Drug: Risperidone
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified May 2012 - Condition: Schizophrenia
Interventions: Drug: Aripiprazole; Drug: Aripiprazole
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified May 2012 - Condition: Schizophrenia
Interventions: Drug: LY2140023; Drug: Olanzapine; Drug: Aripiprazole; Drug: Risperidone; Drug: Quetiapine
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Adolescent Schizophrenia; Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Intervention: Drug: Aripiprazole
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified May 2012 - Condition: Schizophrenia
Interventions: Drug: paliperidone; Drug: risperidone; Drug: haloperidole; Drug: perphenazine; Drug: aripiprazole; Drug: quetiapine; Drug: paliperidone palmitate; Drug: olanzapine
Sponsors: Janssen Scientific Affairs, LLC; Janssen Scientific Affairs, LLC
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Intervention: Drug: escitalopram and adjunctive aripiprazole and placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Condition: Pervasive Developmental Disorder
Intervention: Drug: aripiprazole
Sponsors: Indiana University; Indiana University; National Institute of Mental Health (NIMH); Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Psychotic Disorders
Interventions: Drug: Aripiprazole or Perphenazine; Drug: Metformin; Drug: Olanzapine, quetiapine, risperidone, ziprasidone, aripiprazole, asenapine, iloperidone, or lurasidone
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Johns Hopkins University; University of Maryland; University of North Carolina, Chapel Hill; The Zucker Hillside Hospital
Recruiting - verified April 2012 - Conditions: Cocaine Dependence; Cocaine-Related Disorders; Opioid-Related Disorders
Interventions: Drug: Airipiprazole; Drug: Placebo
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2011 - Condition: Schizophrenia
Interventions: Drug: Aripiprazole; Drug: Risperidone; Drug: Clozapine
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Bipolar Disorder
Intervention: Drug: abilify (aripiprazole)
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; Bristol-Myers Squibb
Recruiting - verified December 2011
 |
Abilify Clinical Trials |
